305 related articles for article (PubMed ID: 22850530)
1. Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury.
Matheeussen V; Jungraithmayr W; De Meester I
Pharmacol Ther; 2012 Dec; 136(3):267-82. PubMed ID: 22850530
[TBL] [Abstract][Full Text] [Related]
2. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
3. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
[TBL] [Abstract][Full Text] [Related]
4. DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury.
Glorie LL; Verhulst A; Matheeussen V; Baerts L; Magielse J; Hermans N; D'Haese PC; De Meester I; De Beuf A
Am J Physiol Renal Physiol; 2012 Sep; 303(5):F681-8. PubMed ID: 22718884
[TBL] [Abstract][Full Text] [Related]
5. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.
Zhong J; Rao X; Rajagopalan S
Atherosclerosis; 2013 Feb; 226(2):305-14. PubMed ID: 23083681
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
[TBL] [Abstract][Full Text] [Related]
8. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
[TBL] [Abstract][Full Text] [Related]
9. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS - a critical overview.
Bernstein HG; Keilhoff G; Dobrowolny H; Steiner J
Rev Neurosci; 2023 Jan; 34(1):1-24. PubMed ID: 35771831
[TBL] [Abstract][Full Text] [Related]
10. What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.
Elmansi AM; Awad ME; Eisa NH; Kondrikov D; Hussein KA; Aguilar-Pérez A; Herberg S; Periyasamy-Thandavan S; Fulzele S; Hamrick MW; McGee-Lawrence ME; Isales CM; Volkman BF; Hill WD
Pharmacol Ther; 2019 Jun; 198():90-108. PubMed ID: 30759373
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
[TBL] [Abstract][Full Text] [Related]
12. Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition.
Beckers PAJ; Gielis JF; Van Schil PE; Adriaensen D
Ann Transl Med; 2017 Mar; 5(6):129. PubMed ID: 28462209
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of incretins in diabetes.
Advani A; Bugyei-Twum A; Connelly KA
Can J Diabetes; 2013 Oct; 37(5):309-14. PubMed ID: 24500557
[TBL] [Abstract][Full Text] [Related]
14. Context-dependent effects of dipeptidyl peptidase 4 inhibitors.
Jackson EK
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):83-90. PubMed ID: 27898522
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.
Chua S; Lee FY; Tsai TH; Sheu JJ; Leu S; Sun CK; Chen YL; Chang HW; Chai HT; Liu CF; Lu HI; Yip HK
J Transl Med; 2014 Dec; 12():357. PubMed ID: 25496837
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors.
Matteucci E; Giampietro O
Curr Med Chem; 2015; 22(13):1573-81. PubMed ID: 25723507
[TBL] [Abstract][Full Text] [Related]
17. GLP-1 agonists and dipeptidyl-peptidase IV inhibitors.
Gallwitz B
Handb Exp Pharmacol; 2011; (203):53-74. PubMed ID: 21484567
[TBL] [Abstract][Full Text] [Related]
18. Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failure.
Salles TA; dos Santos L; Barauna VG; Girardi AC
Int J Mol Sci; 2015 Feb; 16(2):4226-49. PubMed ID: 25690036
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
Sueyoshi R; Woods Ignatoski KM; Okawada M; Hartmann B; Holst J; Teitelbaum DH
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(4):G410-9. PubMed ID: 24970775
[TBL] [Abstract][Full Text] [Related]
20. The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.
O'Leary H; Ou X; Broxmeyer HE
Curr Opin Hematol; 2013 Jul; 20(4):314-9. PubMed ID: 23594692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
